Edwards Lifesciences Corp Quarterly Operating Lease, Payments in USD from Q1 2018 to Q1 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Edwards Lifesciences Corp quarterly/annual Operating Lease, Payments history and growth rate from Q1 2018 to Q1 2025.
  • Edwards Lifesciences Corp Operating Lease, Payments for the quarter ending March 31, 2025 was $7M, a 4.11% decline year-over-year.
  • Edwards Lifesciences Corp annual Operating Lease, Payments for 2024 was $28M, a 8.95% increase from 2023.
  • Edwards Lifesciences Corp annual Operating Lease, Payments for 2023 was $25.7M, a 2.8% increase from 2022.
  • Edwards Lifesciences Corp annual Operating Lease, Payments for 2022 was $25M, a 21.6% decline from 2021.
Operating Lease, Payments, Quarterly (USD)
Operating Lease, Payments, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2025 $7M -$300K -4.11% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-06
Q1 2024 $7.3M +$200K +2.82% Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-06
Q1 2023 $7.1M -$500K -6.58% Jan 1, 2023 Mar 31, 2023 10-Q 2024-04-29
Q1 2022 $7.6M -$100K -1.3% Jan 1, 2022 Mar 31, 2022 10-Q 2023-04-28
Q1 2021 $7.7M +$600K +8.45% Jan 1, 2021 Mar 31, 2021 10-Q 2022-04-28
Q1 2020 $7.1M +$1M +16.4% Jan 1, 2020 Mar 31, 2020 10-Q 2021-04-28
Q1 2019 $6.1M +$6.1M Jan 1, 2019 Mar 31, 2019 10-Q 2020-04-28
Q1 2018 $0 Jan 1, 2018 Mar 31, 2018 10-Q 2019-04-26
* An asterisk sign (*) next to the value indicates that the value is likely invalid.